Read on Twitter
Been buying more #NCYT recently and the main reason is not Covid related. Lots see #NCYT as a Covid stock (including the market) but looking to the future with this company I still see their products being used daily.
1/6
1/6
I see their Q16 and Q32 products being used for all sorts of tests in doctors surgery, care homes, hospitals etc. Having better diagnostics will save the NHS money and allow quicker treatments.
2/6
2/6
The UK desperately needs to sort out its diagnostic framework, look at how much better Germany coped and we need to catch up to them. If another pandemic comes along we can't have such a slow response again and the government know this
3/6
3/6
so they will be investing to stop this happening again. This is just the UK, think about the global possibilities as other countries try to catch up as well!
Look at the recent directors buys, they clearly think the company has a long way to go still.
4/6
Look at the recent directors buys, they clearly think the company has a long way to go still.
4/6
Make up your own mind but when the market understands that #NCYT will be so much more than a covid stock, the current £500m market cap will be a bargain!
I will keep loading when on the dips and look forward to the re-rate.
5/6
I will keep loading when on the dips and look forward to the re-rate.
5/6
With #NCYT the possibilities are far greater than just Covid. Although, it will still be a driver in the short/medium term.
See @TaylorQuant tweets for much better analysis on what the future could be for #NCYT
6/6
See @TaylorQuant tweets for much better analysis on what the future could be for #NCYT
6/6
